Figure 3.

The level of endogenous PKCα and the activated form of PKCα, phospho-PKCα, in HepG2 cells.aHepG2 cell lysates andbrecombinant PKCα (1 ng/lane) were immunoblotted with anti-PKCα serum or anti-phosphoPKCα (Ser657) serum. Bound antibodies were visualized using a chemiluminescence assay

Asai et al. Nanoscale Research Letters 2008 4:229-233   doi:10.1007/s11671-008-9230-5